TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS

Documenti analoghi

• ELEVATED INTERLEUKIN-6 LEVELS IN COVID-19-INFECTED PATIENTS ARE ASSOCIATED WITH MAJOR ADVERSE CARDIAC EVENTS AND/OR MORTALITY
  di: Nguyen, Nicholas, et al.
  Pubblicazione: (2021)
• BRADYARRHYTHMIAS AND MORTALITY IN COVID-19 PATIENTS
  di: Hoang, Lawrence, et al.
  Pubblicazione: (2021)
• PREDICTIVE VALUE OF TROPONIN, NTPROBNP AND SODIUM ON ADVERSE CLINICAL OUTCOMES IN COVID-19
  di: Roman, Aida, et al.
  Pubblicazione: (2021)
• Relation of High-sensitivity Cardiac Troponin I Elevation With Exercise to Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease
  di: Lima, Bruno B., et al.
  Pubblicazione: (2020)
• Predictive power of high sensitivity troponin T for adverse cardiovascular events in major non-cardiac surgery: Predictor power of hs TnT for adverse cariovascular events in mayor non-cardiac surgery
  di: Golubović Mlađan, et al.
  Pubblicazione: (2016-01-01)